PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
289 hedge funds and large institutions have $7.82B invested in PRA Health Sciences, Inc. in 2020 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 110 increasing their positions, 101 reducing their positions, and 28 closing their positions.
32% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 28
24% more capital invested
Capital invested by funds: $6.32B → $7.82B (+$1.51B)
3% more funds holding
Funds holding: 281 → 289 (+8)
9% more repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 101
34% less call options, than puts
Call options by funds: $3.24M | Put options by funds: $4.87M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$103M |
| 2 |
Millennium Management
New York
|
+$30.5M |
| 3 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$15.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.4M |
| 5 |
ESCM
Echo Street Capital Management
New York
|
+$11.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$26.7M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$26.1M |
| 3 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$20.8M |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$15.4M |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
-$15.4M |
PRAH Hedge Fund Activity: Q4 2020 in Review
289 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q4 2020, worth a combined $7.82B — up 24% from $6.32B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new PRAH positions and 28 closed out — a net gain of 9 holders — while 110 added to existing stakes and 101 trimmed.
The largest buyer was Massachusetts Financial Services, adding an estimated $103M. The largest seller was Morgan Stanley, cutting an estimated $26.7M.
- 289 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q4 2020, up from 281 in Q3 2020.
- Funds reported $7.82B of PRA Health Sciences, Inc. stock for Q4 2020, up 24% quarter-over-quarter.
- 37 funds opened new PRA Health Sciences, Inc. positions in Q4 2020 and 28 closed out, a net change of +9 holders.
- The largest PRA Health Sciences, Inc. buyer in Q4 2020 was Massachusetts Financial Services, an estimated $103M added.
- The largest PRA Health Sciences, Inc. seller in Q4 2020 was Morgan Stanley, an estimated $26.7M sold.
Based on aggregated 13F filings for Q4 2020.